[CTXR] QoQ Quarter Result on 30-Sep-2023 [#Q4]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q4]
Profit Trend
QoQ- -17.28%
YoY- -24.44%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,429 -8,400 -9,087 -9,800 -8,335 -10,382 -3,450 109.20%
Tax 144 144 144 144 144 144 144 0.00%
NP -10,573 -8,544 -9,231 -9,944 -8,479 -10,526 -3,594 105.44%
Tax Rate - - - - - - - -
Total Cost 10,573 8,544 9,231 9,944 8,479 10,526 3,594 105.44%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.06 -0.05 -0.06 -0.06 -0.06 -0.07 -0.02 108.14%
EPS Diluted -0.06 -0.05 -0.06 -0.06 -0.06 -0.07 -0.02 108.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.